- New ETFs
- Bond ETFs
- Currency ETFs
- Emerging Market ETFs
- Commodity ETFs
- Broad U.S. Equity ETFs
- Sector ETFs
- Specialty ETFs
Credit Suisse upgraded Medtronic Inc (NYSE: MDT) from “neutral” to “outperform.” Credit Suisse also added MDT to its Focus List and raised the target price for MDT from $41 to $49. According to Credit Suisse, the base business of MDT was stabilizing and the risk/reward profile of MDT stocks was compelling.